Robotic hip brace may help control blood sugar after eating
NCT ID NCT07695441
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This study explores whether walking with a wearable hip exoskeleton changes how the body handles blood sugar after a meal. Healthy adults aged 20 to 65 walked with and without the device, and their glucose and heart rate were measured. The goal is to see if the exoskeleton offers any advantage over regular walking for post-meal glucose control.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Bot-Fit wearable hip exoskeleton
- What this could lead to
- If walking with the exoskeleton improves blood sugar control, it could point toward a simple way to help people manage glucose after meals.
- What could go wrong
- This is a small, early proof-of-concept study in healthy adults, so results may not apply to people with diabetes or other conditions. The device may not show any benefit over normal walking.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
22 people
The number who actually took part.
- Started
-
Mar 2026
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy adults aged 20 to 65 years. * Participants who were able to complete walking trials with and without the wearable hip exoskeleton. * Participants who provided written informed consent before participation. Exclusion Criteria: * Participants with diagnosed metabolic, cardiovascular, neurological, or musculoskeletal disorders. * Participants with conditions that could affect walking ability or safe use of the wearable hip exoskeleton. * Participants taking medications known to affect glucose metabolism. * Participants who were unable to comply with the study procedures.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy adults are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHA University
Seongnam-si, Gyeonggi-do, 13503, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Xbox-Based exergames versus structured Home-Based cognitive training for attention and executive functions in healthy adults
- Neuromodulation with transcranial pulse stimulation of the anterior insula cortex and dorsal anterior cingulate cortex in healthy adults: a randomized, single-blind, three-arm, sham-controlled, pilot trial
- A dead Probiotic's ghost may help tame weight gain
- Can a new device decode how well you sense your own arm?
- Breakfast or fast? a trial puts Prifetrastat's absorption to the test
- Magic mushroom compound may rewire Self-Awareness — scientists put it to the test